| scholarly article | Q13442814 |
| P2093 | author name string | H K Paudel | |
| K Sobue | |||
| M Hashiguchi | |||
| P2860 | cites work | Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262 | Q24313123 |
| Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation | Q24319934 | ||
| Activation-modulated association of 14-3-3 proteins with Cbl in T cells | Q24321362 | ||
| Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine | Q24322674 | ||
| 14-3-3 proteins associate with cdc25 phosphatases | Q24324041 | ||
| Activation of Raf-1 by 14-3-3 proteins | Q24324360 | ||
| Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells | Q24563675 | ||
| Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases | Q24648367 | ||
| 14-3-3zeta binds a phosphorylated Raf peptide and an unphosphorylated peptide via its conserved amphipathic groove | Q27758986 | ||
| Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
| Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration | Q28140796 | ||
| 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine-dependent manner | Q28235588 | ||
| Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 | Q28247771 | ||
| A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity | Q28276506 | ||
| Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) | Q28297419 | ||
| The distribution of tau in the mammalian central nervous system | Q29622896 | ||
| Reversal of Raf-1 Activation by Purified and Membrane-Associated Protein Phosphatases | Q30464289 | ||
| alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356. | Q33872332 | ||
| Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments | Q33983175 | ||
| Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease | Q35490235 | ||
| Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau. | Q38313548 | ||
| Tau protein and the neurofibrillary pathology of Alzheimer's disease | Q40386025 | ||
| Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping | Q40967467 | ||
| Oligomerization activates c-Raf-1 through a Ras-dependent mechanism | Q41168392 | ||
| Phosphorylation of microtubule-associated protein tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with tau phosphorylation in Alzheimer tangles. | Q41229492 | ||
| Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family | Q41436352 | ||
| Association of polyomavirus middle tumor antigen with 14-3-3 proteins | Q41453913 | ||
| The tubulin-binding sequence of brain microtubule-associated proteins, tau and MAP-2, is also involved in actin binding | Q41813380 | ||
| Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau. | Q43412357 | ||
| Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau | Q46127208 | ||
| Protein phosphatase 1 is targeted to microtubules by the microtubule-associated protein Tau. | Q47681968 | ||
| 14-3-3 and its possible role in co-ordinating multiple signalling pathways | Q47986680 | ||
| Purification of 14-3-3 protein and analysis of isoforms in chicken brain. | Q48087654 | ||
| Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies | Q48125013 | ||
| cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. | Q48128979 | ||
| Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein | Q48259445 | ||
| Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding | Q48277664 | ||
| Reversible assembly purification of microtubules without assembly-promoting agents and further purification of tubulin, microtubule-associated proteins, and MAP fragments | Q48392679 | ||
| Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms | Q48571996 | ||
| Residues of 14-3-3 zeta required for activation of exoenzyme S of Pseudomonas aeruginosa. | Q52174174 | ||
| Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. | Q52209534 | ||
| Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state. | Q52210030 | ||
| A novel ligand-binding site in the zeta-form 14-3-3 protein recognizing the platelet glycoprotein Ibalpha and distinct from the c-Raf-binding site. | Q52532830 | ||
| Proline-directed and non-proline-directed phosphorylation of PHF-tau. | Q53203171 | ||
| A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. | Q53296439 | ||
| Phosphorylation Sites on Tau Identified by Nanoelectrospray Mass Spectrometry | Q55919559 | ||
| Raf gets it together | Q60084134 | ||
| Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins | Q71334298 | ||
| Interaction of 14-3-3 with a nonphosphorylated protein ligand, exoenzyme S of Pseudomonas aeruginosa | Q77357874 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phosphorylation | Q242736 |
| P304 | page(s) | 25247-54 | |
| P577 | publication date | 2000-08-18 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | 14-3-3zeta is an effector of tau protein phosphorylation | |
| P478 | volume | 275 |
| Q42694677 | 14-3-3 Proteins in Brain Development: Neurogenesis, Neuronal Migration and Neuromorphogenesis |
| Q35879488 | 14-3-3 Proteins--a focus on cancer and human disease |
| Q40568541 | 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain |
| Q27930016 | 14-3-3 protein targets misfolded chaperone-associated proteins to aggresomes |
| Q38024792 | 14-3-3 proteins in neurological disorders. |
| Q33188355 | 14-3-3 proteins in the nervous system |
| Q41506559 | 14-3-3 proteins interact with the beta-thymosin repeat protein Csp24 |
| Q34405540 | 14-3-3 proteins; bringing new definitions to scaffolding |
| Q89065584 | 14-3-3: A Case Study in PPI Modulation |
| Q37149637 | 14-3-3s are potential biomarkers for HIV-related neurodegeneration |
| Q24297986 | 14-3-3zeta facilitates GSK3beta-catalyzed tau phosphorylation in HEK-293 cells by a mechanism that requires phosphorylation of GSK3beta on Ser9 |
| Q36109281 | 14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells |
| Q47134911 | 14-3-3ζ loss leads to neonatal lethality by microRNA-126 downregulation-mediated developmental defects in lung vasculature |
| Q52656299 | 14-3-3ζ regulates immune response through Stat3 signaling in oral squamous cell carcinoma. |
| Q24310599 | A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease |
| Q38731927 | Actin dynamics and cofilin-actin rods in alzheimer disease |
| Q28250508 | Alpha-synuclein and tau: teammates in neurodegeneration? |
| Q48569929 | Antioxidant effects of carnitine supplementation on 14-3-3 protein isoforms in the aged rat hippocampus detected using fully automated two-dimensional chip gel electrophoresis |
| Q40066989 | Arachidonic acid binds 14-3-3zeta, releases 14-3-3zeta from phosphorylated BAD and induces aggregation of 14-3-3zeta |
| Q36391128 | Bacterial co-expression of human Tau protein with protein kinase A and 14-3-3 for studies of 14-3-3/phospho-Tau interaction |
| Q38023859 | Biochemistry and cell biology of tau protein in neurofibrillary degeneration |
| Q36778845 | Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease |
| Q42872730 | Derailed intraneuronal signalling drives pathogenesis in sporadic and familial Alzheimer's disease. |
| Q36005292 | Differential functions of 14-3-3 isoforms in vertebrate development |
| Q27864126 | Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease |
| Q44216082 | Drosophila 14-3-3/PAR-5 is an essential mediator of PAR-1 function in axis formation |
| Q38684995 | Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology |
| Q24316127 | Effect of phosphorylation on interaction of human tau protein with 14-3-3zeta |
| Q53763933 | Expression of 14-3-3 zeta and interaction with protein kinase C in the rat retina in early diabetes. |
| Q43131515 | Familial FTDP-17 missense mutations inhibit microtubule assembly-promoting activity of tau by increasing phosphorylation at Ser202 in vitro |
| Q50658598 | Gene-gene interaction between 14-3-3 zeta and butyrylcholinesterase modulates Alzheimer's disease risk. |
| Q39108385 | Global protein profiling reveals anti-EGFR monoclonal antibody 806-modulated proteins in A431 tumor xenografts |
| Q43867592 | Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules |
| Q40679799 | Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3ζ via deacetylation of lysines within the 14-3-3ζ binding pocket |
| Q43732934 | Hyperosmotic stress-induced apoptosis and tau phosphorylation in human neuroblastoma cells |
| Q24304395 | Identification and characterization of the interaction between tuberin and 14-3-3zeta |
| Q40266081 | Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells |
| Q36939900 | Identification of Novel Tau Interactions with Endoplasmic Reticulum Proteins in Alzheimer's Disease Brain |
| Q24534993 | Identification of cofilin and LIM-domain-containing protein kinase 1 as novel interaction partners of 14-3-3 zeta |
| Q42527596 | Immune response gene expression increases in the aging murine hippocampus. |
| Q57531336 | Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes |
| Q33292483 | Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. |
| Q34348161 | Intermediate filaments mediate cytoskeletal crosstalk |
| Q34878802 | Is tau a suitable therapeutical target in tauopathies? |
| Q36031983 | Lessons from tau-deficient mice |
| Q38108308 | Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion |
| Q52917513 | Localization of 14-3-3δ/ξ on the neuronal cell surface. |
| Q34177990 | Loss of Hsp110 Leads to Age-Dependent Tau Hyperphosphorylation and Early Accumulation of Insoluble Amyloid β |
| Q39038460 | Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins. |
| Q35042712 | NeuroGeM, a knowledgebase of genetic modifiers in neurodegenerative diseases |
| Q28537815 | Overexpression of 14-3-3z promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons |
| Q48195821 | Oxidative damage of 14-3-3 zeta and gamma isoforms in Alzheimer's disease and cerebral amyloid angiopathy |
| Q24530623 | PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin |
| Q24318991 | Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3zeta |
| Q58169387 | Phosphorylation of ser246residue in integrin‐linked kinase 1 by serum‐ and glucocorticoid‐induced kinase 1 is required to form a protein‐protein complex with 14–3–3 |
| Q39181325 | Physiological and Pathological Roles of 15-Deoxy-Δ12,14-Prostaglandin J2 in the Central Nervous System and Neurological Diseases |
| Q44497833 | Polyglutamine neurodegeneration: minding your Ps and Qs. |
| Q98463750 | Presenilin 1 phosphorylation regulates amyloid-β degradation by microglia |
| Q28244030 | Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid |
| Q44827073 | Proteome analysis of DNA damage-induced neuronal death using high throughput mass spectrometry |
| Q31155409 | Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. |
| Q42247540 | Proteomic analysis of 14-3-3 zeta binding proteins in the mouse hippocampus |
| Q35373453 | Proteomic changes in the cortex membrane fraction of genetic absence epilepsy rats from Strasbourg |
| Q33204250 | Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection |
| Q37295665 | Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study |
| Q33291681 | Proteomic screen in the simple metazoan Hydra identifies 14-3-3 binding proteins implicated in cellular metabolism, cytoskeletal organisation and Ca2+ signalling |
| Q36533922 | Proteomics in neurodegeneration--disease driven approaches. |
| Q51112497 | Quantitative mapping of microtubule-associated protein 2c (MAP2c) phosphorylation and regulatory protein 14-3-3ζ-binding sites reveals key differences between MAP2c and its homolog Tau. |
| Q39767003 | Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation |
| Q33893342 | Quantitative proteomic analysis of mitochondria in aging PS-1 transgenic mice |
| Q28478846 | Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopes |
| Q92856681 | Role of Tau as a Microtubule-Associated Protein: Structural and Functional Aspects |
| Q33559303 | Roles of tau protein in health and disease |
| Q94521330 | SWATH-MS analysis of cerebrospinal fluid to generate a robust battery of biomarkers for Alzheimer's disease |
| Q27702573 | Stabilizer-Guided Inhibition of Protein-Protein Interactions |
| Q57531351 | Stabilizer-Guided Inhibition of Protein-Protein Interactions |
| Q38016600 | Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience |
| Q33495226 | Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes |
| Q43760336 | Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells |
| Q27027415 | Tau and tauopathies |
| Q43807410 | Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells |
| Q46633367 | Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly |
| Q35103017 | The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes |
| Q28748812 | The 14-3-3ζ protein binds to the cell adhesion molecule L1, promotes L1 phosphorylation by CKII and influences L1-dependent neurite outgrowth |
| Q28251868 | The DISC locus in psychiatric illness |
| Q27937187 | The Saccharomyces cerevisiae Fin1 protein forms cell cycle-specific filaments between spindle pole bodies |
| Q34566338 | Transgenic overexpression of 14-3-3 zeta protects hippocampus against endoplasmic reticulum stress and status epilepticus in vivo. |
| Q33822953 | Unchanged survival rates of 14-3-3gamma knockout mice after inoculation with pathological prion protein |
| Q24309450 | p21-activated kinase 1 phosphorylates and regulates 14-3-3 binding to GEF-H1, a microtubule-localized Rho exchange factor |
Search more.